Early Palliative Care Can Lessen Hospital Stays, Improve Well-Being
Researchers say new study shows early palliative care lessens hospital stays and deaths, and improves cancer patients’ physical and mental well-being.
Early Palliative Care Can Lessen Hospital Stays, Improve Well-Being
It is never too early for a patient diagnosed with mesothelioma — or most any cancer — to start consulting with a palliative care specialist, according to a recent study.
The message from researchers at the University of Texas MD Anderson Cancer Ce…
Simple Blood Test Using UV Light Could Detect Cancer
Researchers in the U.K. developed a new blood test that detects cancer after exposing a person’s white blood cells to UV light.
Simple, New Blood Test Could Lead to Earlier Mesothelioma Treatment
Japanese researchers developed a simple blood test that could more accurately diagnose mesothelioma, leading to earlier cancer treatment.
Talc Pleurodesis vs. Partial Pleurectomy: British Researchers Cite Mixed Results
British researchers compared benefits and disadvantages of the complex video-assisted thoracoscopic partial pleurectomy and less invasive talc pleurodesis.
Mesothelioma Clinical Trial Should Prove Worth of Photodynamic Therapy
Armed with a new $8 million grant, researchers at Penn Medicine hope to prove that photodynamic therapy is highly effective at treating pleural mesothelioma.
Immunotoxin SS1P Proving Effective Against Mesothelioma
A clinical trial at the National Cancer Institute involving a genetically engineered immunotoxin is showing promise in the fight against mesothelioma.
CDC Reinstates $2.2M Grant to Fund the Mesothelioma Tissue Bank
The Centers for Disease Control and Prevention reinstated a $2.2 million research grant to continue research at the National Mesothelioma Virtual Bank.
Could Red Wine Enhance Effectiveness of Chemotherapy for Mesothelioma?
Research shows that combining red wine’s resveratrol with leukemia drug clofarabine could overcome chemoresistance in mesothelioma patients.
Immunotherapy Clinical Trial Showing Promise in Stopping Mesothelioma Recurrence
Doctors at MD Anderson in Houston are testing a Wilms tumor (WT1) vaccine that triggers body’s immune system to fight mesothelioma.
Study: Higher Survival Rates for Women Could Lead to New Treatment Options
Women survive mesothelioma at a much higher rate than do men, leading researchers toward the development of a new mechanism with which to treat the disease in the future.
Vietnam Vet Credits Strong Will, Alternative Medicine to Mesothelioma Survival
Army soldier Billy K. was told he would never walk again. After 50 years and a mesothelioma diagnosis, he fights every day to keep his hopes alive.
Ochsner Cancer Institute Considers Expanding Treatment Program into Latin America
Dr. Rodney Landreneau, director of the Ochsner Cancer Institute in New Orleans, is looking to expand mesothelioma treatments in Latin America.
Study: Majority of Peritoneal Mesothelioma Patients Avoid Surgery, Despite Benefits to Survival
Research shows a majority of peritoneal mesothelioma patients are not undergoing surgery, which can improve survival rates.
New Leadership at Brigham and Women’s Bolsters Mesothelioma Care
Dr. Raphael Bueno replaces Dr. David Sugarbaker as the new chief of thoracic surgery at Boston’s Brigham & Women’s Hospital.